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Crystal Structure of a Procaspase-7 Zymogen:
Mechanisms of Activation and Substrate Binding
teolytic cleavage at specific internal Asp residues to
separate the large and small subunits of the mature
caspase (Srinivasula et al., 1998a). Once activated, the
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effector caspases are responsible for the proteolytic1 Department of Molecular Biology
degradation of a broad spectrum of cellular targets,Lewis Thomas Laboratory
leading ultimately to cell death (Thornberry and Lazeb-Princeton University
nik, 1998). Among the effector caspases, caspase-7Princeton, New Jersey 08544
shares 54% sequence identity with caspase-3 (Fernan-2 Kimmel Cancer Center
des-Alnemri et al., 1995); these two caspases exhibit233 South 10th Street
highly similar structures and function.Thomas Jefferson University
Because the modulation of caspase activity couldPhiladelphia, Pennsylvania 19107
prove important for the therapeutic intervention of many
diseases, structural characterization of caspases has
been a center of focus in the apoptosis field (Shi, 2001).Summary
Structural information is now available on caspase-1
(Walker et al., 1994; Wilson et al., 1994), caspase-3 (MittlApoptosis is primarily executed by active caspases,
et al., 1997; Rotonda et al., 1996), caspase-7 (Wei et al.,which are derived from the inactive procaspase zymo-
2000), and caspase-8 (Blanchard et al., 1999; Watt etgens through proteolytic cleavage. Here we report the
al., 1999). Indeed, peptide-based inhibitors of caspasescrystal structures of a caspase zymogen, procas-
have shown efficacy in animal models of several clinicalpase-7, and an active caspase-7 without any bound
disorders, including stroke (Cheng et al., 1998; Endresinhibitors. Compared to the inhibitor-bound caspase-
et al., 1998), traumatic brain injury (Yakovlev et al., 1997),7, procaspase-7 zymogen exhibits significant struc-
and fulminant liver destruction (Rodriguez et al., 1996).tural differences surrounding the catalytic cleft, which
To improve the design and efficacy of potential drugs,precludes the formation of a productive conformation.
it is important to understand the fundamental mecha-Proteolytic cleavage between the large and small sub-
nisms of caspase activation and substrate/inhibitorunits allows rearrangement of essential loops in the
binding.active site, priming active caspase-7 for inhibitor/sub-
However, despite intense effort, all reported structuralstrate binding. Strikingly, binding by inhibitors causes
information on caspases to date is restricted to cas-a 180 flipping of the N terminus in the small subunit,
pases bound with designed or natural inhibitors (Chaiwhich interacts with and stabilizes the catalytic cleft.
et al., 2001; Huang et al., 2001; Riedl et al., 2001). InThese analyses reveal the structural mechanisms of
particular, there is no structural information on any pro-caspase activation and demonstrate that the inhibitor/
caspase zymogen or any active caspase without boundsubstrate binding is a process of induced fit.
cofactors. Consequently, it is entirely unknown how pro-
caspase zymogens are activated and what structuralIntroduction
changes are associated with the interdomain cleavage.
In addition, although the catalytic pocket is highly similarApoptosis plays an essential role in the development of
in reported caspase structures, it is unclear whether this
all multicellular organisms and the homeostasis of adult
rigid conformation is preformed or induced by inhibitor
tissues (Horvitz, 1999; Jacobson et al., 1997; Steller,
binding. This distinction is particularly important for the
1995). Alterations in apoptotic pathways have been im- discovery of potent caspase inhibitors.
plicated in many diseases, such as cancer and neurode- To understand the fundamental mechanisms of cas-
generative disorders (Thompson, 1995; Yuan and Yank- pase activation and substrate/inhibitor binding, we de-
ner, 2000). The mechanism of apoptosis is remarkably termined the crystal structures of an unprocessed pro-
conserved across species, executed with a cascade of caspase-7 zymogen and a processed active caspase-7.
sequential activation of initiator and effector caspases These structures reveal large conformational changes
(Budihardjo et al., 1999; Thornberry and Lazebnik, 1998). associated with the interdomain cleavage, and, in con-
Caspases are a family of cysteine proteases that junction with the structure of caspase-7 bound to an
cleave their substrates after an aspartate residue. Since inhibitor (Chai et al., 2001; Huang et al., 2001; Wei et
the discovery of caspase-1 (also known as interleukin al., 2000), provide a structural mechanism for caspase
1-converting enzyme or ICE) (Cerreti et al., 1992; activation and substrate/inhibitor binding. This mecha-
Thornberry et al., 1992), 13 others have been reported, nism explains a body of published evidence and serves
of which at least eight are involved in programmed cell as a general framework for understanding caspases.
death. All caspases are produced in cells as catalytically
inactive zymogens and must be proteolytically pro- Results
cessed to become active proteases. The activation of
an effector caspase, such as caspase-7, is performed Structure of an Unprocessed
by an initiator caspase, such as caspase-9, through pro- Procaspase-7 Zymogen
The full-length procaspase-7 zymogen contains 303
amino acids. When overexpressed in bacteria, autocata-3 Correspondence: yshi@molbio.princeton.edu
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Table 1. Data Collection and Statistics from the Crystallographic Analysis
Data set Procaspase-7 (NSLS-X25) Caspase-7 (NSLS-X25)
Spacegroup P3221 P3221
Resolution (A˚) 99.0–2.70 99.0–2.60
Total observations 97,318 150,937
Unique observations 21,329 23,466
Data coverage 90.9% 89.2%
Rsym (outer shell) 0.048 (0.270) 0.061 (0.180)
Refinement
Resolution range (A˚) 20–2.70 20–2.60
Number of reflections (I  0.5) 20,735 22,194
Rworking/Rfree 22.7%/25.3% 23.2%/25.7%
Number of atoms 3,692 3,706
Number of waters 82 49
Rmsd bond length (A˚) 0.008 0.009
Rmsd bond angles (degree) 1.62 2.12
Rsym  hi | Ih,i  Ih | / hiIh,i, where Ih is the mean intensity of the i observations of symmetry related reflections of h. R   | Fobs  Fcalc | /
Fobs, where Fobs  FP, and Fcalc is the calculated protein structure factor from the atomic model (Rfree was calculated with 5% of the reflections).
Rmsd in bond lengths and angles are the deviations from ideal values, and the rmsd deviation in B factors is calculated betwen bonded
atoms.
lytic cleavage after Asp198 gives rise to a fully active (Figure 2A). However, in the procaspase-7 zymogen,
loop L2 is flipped by 180, disallowing the formation ofcaspase-7. To prevent this proteolytic activation, we
mutated the catalytic residue Cys186 to Ala. This pro- this loop-bundle structure. These structural rearrange-
ments explain why the procaspase-7 zymogen does notcaspase-7 variant (C186A) was expressed as a single
contiguous polypeptide, purified to homogeneity, and possess detectable catalytic activity.
The procaspase-7 zymogen is a single contiguouscrystallized. The structure was determined by molecular
polypeptide chain, with loop L2 linking the large andreplacement and refined at 2.7 A˚ resolution with crystal-
the small subunits. This interdomain loop contains thelographic working and free R factors of 22.7% and
cleavage site (Ile195-Gln196-Ala197-Asp198) for the ac-25.3%, respectively (Table 1 and Figure 1).
tivation of procaspase-7, which requires a certain de-Similar to the active caspase-7, the procaspase-7 zy-
gree of flexibility in this region for binding to the activemogen comprises two catalytic units, each containing
sites. In the crystals, there was no clear electron den-a central 6-stranded  sheet and five 	 helices (Figure
sity for part of the L2 loop (residues 190–203) that cen-1A). Four surface loops (L1–L4) emanate from these core
ters on the cleavage site, confirming that these regionsstructural elements, forming a potential catalytic site.
are indeed highly flexible and disordered in solutionCompared to the inhibitor-bound caspase-7 (Chai et
(Figure 1A).al., 2001), the core structural elements remain nearly
Each heterodimer of caspase-7 may be derived fromidentical, with less than 0.8 A˚ root-mean-square devia-
the same polypeptide chain, or from two separate poly-tion (Rmsd) for all 360 aligned C	 atoms (Figure 1B).
peptide chains as proposed by an interdigitating model.However, three of the four active site loops adopt drasti-
These two models cannot by distinguished by in vivocally different conformations (Figures 1B and 1C). Loop
studies, as the presence of other caspases inevitablyL3, which forms the base of the catalytic groove in the
complicates interpretation of results. Recent in vitroactive caspase-7, expands and moves out of the base
studies indicate that each heterodimer of caspase-9 is(Figure 1C). Loop L4, which forms one side of the cata-
derived from a single polypeptide (Srinivasula et al.,lytic groove in the active caspase-7 (Chai et al., 2001;
1998a). In the crystals, the N terminus of the small sub-Huang et al., 2001), rotates 60 and moves in the oppo-
unit in one heterodimer traverses along the interfacesite direction as L3, further flattening the active site
between two heterodimers and comes close to the Cpocket (Figure 1C). Most importantly, loop L2, which
terminus of the large subunit in the same heterodimer, ascontains the catalytic residue Cys186, changes its direc-
judged by electron density (Figure 1A). This arrangementtion by 90 and makes this residue inaccessible to sol-
supports the conclusion that each heterodimer resultsvent (Figure 1C). Among the four loops, only L1 retains
from the same polypeptide. Based on this observation,its active site conformation (Figure 1C).
we term the two interdomain loops L2 and L2, respec-Compared to the catalytic groove in the active cas-
tively (Figure 1A).pase-7 formed by the four loops (Figure 1D), these struc-
tural rearrangements in the procaspase-7 zymogen do
not give rise to a recognizable substrate binding site Structural Rearrangements in the Loop-Bundle
(Figure 1E). In particular, loops L4, L2, and L2 form In the active caspase-7 bound with peptide inhibitors,
a “loop-bundle” through numerous interactions in the the catalytic groove is well defined by four surrounding
inhibitor-bound caspase-7 (Chai et al., 2001; Huang et loops (Chai et al., 2001; Huang et al., 2001) (Figures
al., 2001) (Figures 1C and 2A). This loop-bundle stabi- 1B and 1C). The productive positioning of the catalytic
lizes the conformation of the active site loop L2 as well residue Cys186 is facilitated by the extended conforma-
tion of the L2 loop (Figure 2A). The L2 loop, on the otheras the overall shape and fold of the catalytic groove
Structure of Procaspase-7 Zymogen
401
Figure 1. Structural Comparison of the Unprocessed Procaspase-7 Zymogen and the Active Caspase-7 Bound with an XIAP Fragment (PDB
code 1I51)
(A) Overall structure of the procaspase-7 zymogen. The structure is shown in blue, with the N termini of the small subunits highlighted in
yellow. The electron density (omit map) surrounding the N termini of the small subunits, shown at 2.5 , was calculated by simulated annealing
using CNS (Brunger et al., 1998). The four loops that define the catalytic groove are labeled.
(B) Superposition of the unprocessed procaspase-7 zymogen (blue) with the active caspase-7 (green) bound with an XIAP fragment. For
clarity, the XIAP fragment is not shown here. The open termini of the interdomain loops (L2 and L2) in procaspase-7 are indicated by red
dots. The residues between these termini are flexible and disordered in the crystals.
(C) Close-up comparison of the four loops that define the catalytic cleft. The arrows indicate structural changes from the procaspase-7
zymogen to the active caspase-7. The catalytic residue is colored gold and red, respectively, for the active caspase-7 and the zymogen. The
orientation for procaspase-7 is the same for (A), (B), and (C).
(D) Surface representation of the catalytic groove in the active caspase-7 bound with an XIAP fragment. For an unobstructed view, the XIAP
fragment is not shown.
(E) Surface representation of the corresponding region in the procaspase-7 zymogen. Note the disappearance of the catalytic groove. The
procaspase-7 zymogen is shown in an identical orientation as the active caspase-7 (D). Figures 1, 2, and 4 were prepared using MOLSCRIPT
(Klaulis, 1991) and GRASP (Nicholls et al., 1991).
hand, is involved in networks of contacts with the L4 not only stabilize the L2 loop but also engage the L4
loop to maintain a productive conformation for the cata-and L2 loops, forming the so-called loop-bundle (Figure
2A). There are a total of 11 hydrogen bonds and numer- lytic cleft to which the inhibitors/substrates bind.
In the procaspase-7 zymogen, the loop-bundle isous van der Waals interactions in the loop-bundle re-
gion, centering on residues Asp192 of the L2 loop and completely dissolved (Figure 2B). Rather than engaging
the N-terminal portions of loops L2 and L4, the N termi-Pro214 of the L2 loop (Figure 2A). These interactions
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Figure 2. A Structural Mechanism for the Ac-
tivation of Procaspase-7
(A) Stabilization of the catalytic cleft by the
loop-bundle in the active caspase-7 bound
with an XIAP fragment (PDB code 1I51). The
loop-bundle is nucleated by the free N termi-
nus (L2) of the small subunit. These inter-
actions occur between two adjacent cas-
pase-7 heterodimers. Fragments from these
two heterodimers are colored green and blue,
respectively. Their side chains are colored
gold and yellow, respectively. Hydrogen
bonds are represented by red dashed lines.
(B) The uncleaved interdomain loop in the
procaspase-7 zymogen is restrained to adopt
a different set of interactions. Fragments from
two adjacent heterodimers are colored gray
and brown, respectively.
(C) Superposition of the loop-bundle in the
active caspase-7 and the corresponding re-
gions in the procaspase-7 zymogen. Coloring
scheme is the same as in (A) and (B). The
orientation of active caspase-7 is the same
for (A) and (C). The orientation of procas-
pase-7 in this panel is highly similar (a rotation
of 5 along vertical axis) to that in (B).
(D) Sequence alignment of the L2 loop region
for caspase-3, -6, -7, and -9. The catalytic
Cys is highlighted in red, while conserved res-
idues are colored yellow. Interactions in the
procaspase-7 zymogen and the XIAP-bound
active caspase-7 are shown below and above
the alignment, respectively. Residues that
make hydrogen bonds in the loop-bundle re-
gion with their side chain and main chain
groups are indicated by red arrows and red
squares, respectively. Residues that make
van der Waals contacts are identified by blue
squares. The scissors indicate the position of
activation cleavage in procaspase-7 and -3.
nus of the L2 loop folds back to interact with the Sequence alignment reveals that the two central resi-
dues in the loop-bundle, Asp192 on loop L2 and Pro214C-terminal portions of loops L2 and L4, existing in a
“closed” conformation. These interactions, exclusively on loop L2, are invariant among caspases (Figure 2D).
Other residues involved in stabilizing the loop-bundle incomprising van der Waals contacts (Figure 2B), appear
to be weaker than those observed in the inhibitor-bound the inhibitor-bound caspase-7 and the corresponding
region in the procaspase-7 zymogen are also generallycaspase-7 (Figure 2A).
Why is there such a drastic conformational change conserved. These observations suggest that the activa-
tion mechanism observed for caspase-7 is likely truebetween the procaspase-7 zymogen and the inhibitor-
bound caspase-7 (Figure 2C)? One essential reason re- for other caspases such as caspase-3 and caspase-6.
Supporting this analysis, the inhibitor-bound caspase-3sides in the unprocessed nature of the procaspase-7
zymogen. As the C-terminal portion of the loop L2 is contains a highly similar loop-bundle that stabilizes the
substrate-bound conformation (Mittl et al., 1997; Ro-covalently connected to its N-terminal portion which
resides near the catalytic site on the opposite end (Fig- tonda et al., 1996; Wei et al., 2000). Compared to cas-
pase-7, caspase-9 contains an expanded L2 loop (Fig-ure 1A), the L2 loop is physically occluded from being
able to form a loop-bundle with loops L2 and L4. This ure 2D), which may allow enough conformational
flexibility such that caspase-9 does not need an interdo-inability can only be removed by a proteolytic cleavage
after Asp198, which allows the L2 loop to switch to its main cleavage to have the L2 loop move to its produc-
tive conformation. This is consistent with the findingopen conformation as observed in the inhibitor-bound
caspase-7 (Figure 2C). that procaspase-9 exhibits a basal level of activity in
Structure of Procaspase-7 Zymogen
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the absence of any proteolytic cleavage (Srinivasula et
al., 2001; Stennicke et al., 1999).
The N-Terminal Prodomain Is Dispensable
for Caspase-7 Activity
In the crystals of the procaspase-7 zymogen, there is
no electron density for the N-terminal prodomain se-
quences (residues 1–55), suggesting that these se-
quences are not necessary for the activation of procas-
pase-7 or the activity of mature caspase-7. Supporting
this observation, a caspase-7 variant with the N-terminal
50 residues deleted is fully able to undergo autoactiva-
tion when overexpressed in bacteria (Chai et al., 2001).
In addition, this variant, when purified to homogeneity,
exhibits catalytic activity indistinguishable to that of the
wild-type caspase-7 (data not shown). Furthermore,
consistent with our structural observations, the pres-
ence or absence of the N-terminal prodomain has no
impact on the interactions between caspase-7 and XIAP
(Chai et al., 2001). Thus, the N-terminal prodomain is
dispensable for the activation of procaspase-7 or the
activity of mature caspase-7.
The Loop-Bundle Is Indispensable for Substrate
Binding and Catalysis
Compared to the closed conformation in the procas-
pase-7 zymogen, the L2 loop in the inhibitor-bound
caspase-7 is flipped 180, existing in an open conforma-
tion and stabilizing the active site loops L2 and L4 (Figure
2). This structural observation demonstrates that the
loop-bundle is important for the binding of inhibitors/
substrates and the catalytic activity of caspase-7.
To confirm this conclusion, we generated three cas-
pase-7 variants (Figure 3A), each of which contains an
invariant large subunit (residues 51–198) and a distinct
small subunit. This was achieved by coexpression of
the large subunit in one vector and the small subunit in
another compatible vector in bacteria (see Experimental
Procedures). Thus, these caspase-7 variants represent
their “cleaved” or “active” form. The only difference is
that, relative to the wild-type (wt) caspase-7, the 
S and

L variants contain deletion of residues 199–205 and
199–215, respectively (Figure 3A). Since the removal of
residues 212–215 eliminates the formation of the loop-
Figure 3. The Formation of the Loop-Bundle Is Indispensable tobundle, caspase-7 (
L) is expected to exhibit decreased
Substrate/Inhibitor Binding and Catalysis for Caspase-7binding efficiency for inhibitors/substrates and de-
(A) Schematic diagram of three caspase-7 variants. Using a coex-creased catalysis. In contrast, the caspase-7 (
S) variant
pression strategy, these proteins were produced in their “cleaved”
is expected to behave like the wt caspase-7. form (see Experimental Procedures for details).
First, we examined the ability of these caspase-7 vari- (B) Interactions between XIAP-BIR2 (residues 124–240) and the three
ants to interact with the BIR2 domain (residues 124–240) caspase-7 variants. The interaction was examined by GST-mediated
pull-down assays (see Experimental Procedures for details). Forof XIAP, which potently inhibits caspase-7 (Chai et al.,
each caspase-7 variant, the left and right lanes indicate the input2001; Huang et al., 2001). As expected, both the wt
protein and the final complex, respectively. The molecular weightcaspase-7 and the 
S variant formed a stable complex
of procaspase-7 (lane 5) is 3 kDa smaller than that of GST-BIR2.
with a fusion protein between XIAP-BIR2 and glutathi- (C) A time course of procaspase-9 cleavage by the three caspase-7
one S-transferase (GST) (Figure 3B, lanes 2 and 8). In variants. p37 represents the cleaved product. A small fraction (7%)
sharp contrast, the 
L variant was unable to bind XIAP- of the substrate procaspase-9 (C287A) was partially cleaved during
purification, as indicated in the first lanes of the SDS-PAGE gels (0BIR2 (Figure 3B, lane 4). As a control, we also show that
min). The extent of cleavage is also plotted as a function of time inthe procaspase-7 zymogen was unable to form a stable
the lower panel for all three caspase-7 variants.complex with XIAP-BIR2 (Figure 3B, lane 6), presumably
due to the closed conformation of the L2 loop.
Next, we examined the catalytic activity of these cas- in procaspase-9, producing a p37 large subunit and a
p10 small subunit. To prevent autocleavage, we mutatedpase-7 variants, using procaspase-9 as a substrate (Fig-
ure 3C). Caspase-7 is able to cleave after residue Asp330 the catalytic residue Cys286 to Ala in the full-length
Cell
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Figure 4. Structural Comparison of the Procaspase-7 Zymogen and the Isolated Active Caspase-7 without any Bound Cofactors
(A) Overall structure of the active caspase-7 without bound cofactors. The structure is shown in pink, with the N termini of the small subunits
highlighted in yellow. The electron density (omit map) surrounding these regions, shown at 2.5 , was calculated by simulated annealing using
CNS (Brunger et al., 1998). The four loops that define the catalytic groove are indicated.
(B) Superposition of the active caspase-7 without bound cofactors (pink), the procaspase-7 zymogen (blue), and the active caspase-7 (green)
bound with an XIAP fragment. For clarity, the XIAP fragment is not shown.
(C) Closeup comparison of the four loops that define the catalytic cleft. Coloring scheme is the same as (B). Compared to a closed conformation
in the procaspase-7 zymogen and the isolated active caspase-7, the L2 loop switches to an open conformation in the inhibitor-bound
caspase-7.
procaspase-9 (residues 1–416) and purified the result- gers a 180 flipping of the L2 loop in the active cas-
pase-7, changing its closed conformation in the isolateding protein to homogeneity. Equal amounts of the cas-
pase-7 variants were incubated with the procaspase-9 caspase-7 to an open form in the loop-bundle in the
inhibitor-bound caspase-7. This movement is appar-(C286A) substrate; the cleavage efficiency was moni-
tored by SDS-PAGE and Coomassie staining (Figure ently prohibited in the procaspase-7 zymogen prior to
cleavage at Asp198. Therefore, the procaspase-7 zymo-3C). In agreement with the binding results (Figure 3B),
caspase-7 (
S) displayed the same level of catalytic gen is unable to interact with substrates or inhibitors
(Figure 3B).activity as the wt protein, whereas caspase-7 (
L) was
only marginally active (Figure 3C). Thus, the interdomain cleavage initiates a conforma-
tional change in the active site loops and primes cas-
pase-7 for substrate/inhibitor binding, and the actual
Structure of an Isolated Active Caspase-7
binding by substrates/inhibitors completes the confor-
To further investigate the mechanisms of caspase-7 ac-
mational change to a fully productive state (Figure 5).
tivation, we crystallized the active caspase-7 free from
The intrinsic conformational flexibility of the active site
any bound inhibitors and determined its structure at
loops constitutes an important consideration for the de-
2.6 A˚ resolution (Figure 4A and Table 1). The space
sign and screening of caspase inhibitors.
group for the crystals of this caspase-7 is P3221, the
same as that for the procaspase-7 zymogen and that
for the active caspase-7 bound with a peptide inhibitor Discussion
(Chai et al., 2001; Huang et al., 2001). This facilitates
comparisons among the three structures, as they share Our structural analyses demonstrate that the conforma-
tion of the active site loops of procaspase-7 zymogen,the same set of crystal lattice contacts.
Surprisingly, although the isolated active caspase-7 particularly that of the L2 and L2 loops, is ineffective
for substrate/inhibitor binding. The underlying restraintis somewhat more similar to the inhibitor-bound cas-
pase-7 than the procaspase-7 zymogen, significant is the covalent linkage in the interdomain region that
precludes the formation of a productive conformationstructural differences remain (Figure 4B). Most strik-
ingly, despite cleavage after Asp198, the loop L2 in the (Figure 5). Cleavage after Asp198 leads to some re-
arrangement in loops L2, L3, and L4 (Figure 4C), whichisolated caspase-7 still exists in the closed conforma-
tion, mimicking the procaspase-7 zymogen (Figure 4A). adopt conformations that are more similar to those in
the inhibitor-bound caspase-7 (Figure 5). The critical L2Consequently, the loop-bundle is not properly assem-
bled and the catalytic cleft is not well defined (Figure loop, however, retains a closed conformation, presum-
ably a lower energy state. Inhibitor/substrate binding4C). Nevertheless, the L3 and L4 loops in the isolated
caspase-7 have moved closer to their productive con- removes the energy barrier and induces the flipping of
the L2 loop and subsequent formation of a loop-bundle,formation after the activation cleavage (Figure 4).
This unanticipated finding indicates that the isolated stabilizing the inhibitor/substrate-bound conformation
(Figure 5). Consequently, the four active site loops, L1,active caspase-7 adopts a conformation intermediate
between that of the zymogen and that of the inhibitor- L2, L3, and L4, as well as the critical L2 loop, appear
to be well-ordered and fairly rigid, as judged by theirbound caspase-7. Thus, inhibitor/substrate binding trig-
Structure of Procaspase-7 Zymogen
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cleavage site was implicated in the maintenance of pro-
caspase-3 dormancy (Roy et al., 2001). The underlying
mechanism was attributed to multiple ionic interactions
(Roy et al., 2001). The corresponding residues for this
tripeptide are conserved in caspase-7 (Asp204-Thr205-
Asp206) (Figure 2D) and are visible in the electron den-
sity map. However, these residues are not involved in
multiple ionic interactions in the crystal structure. In our
own experience, the reasons for increased proenzyme
dormancy are hard to pinpoint, particularly in the ab-
sence of relevant structural information. For example,
the missense mutation D168A in procaspase-7 signifi-
cantly increased its proenzyme dormancy (our unpub-
lished data). Our structural studies, together with pub-
lished evidence (Srinivasula et al., 1998a, 1998b; Wang
et al., 1999), unambiguously demonstrate that the proen-
zyme dormancy of caspases is predominantly due to
the covalent linkage between the large and the small
subunits.
The activation mechanism of procaspase-7 bears an
interesting analogy to the serpin-mediated inhibition of
serine proteases. A prototypical serpin, 	1-antitrypsin,
inhibits the catalytic activity of trypsin by covalently trap-
ping trypsin through an ester linkage; the serpin-bound
protease undergoes dramatic conformational change
and exhibits a deformed catalytic site (Huntington et
Figure 5. Schematic Diagram of Caspase Activation and Substrate/ al., 2000). Similarly, the procaspase-7 zymogen is alsoInhibitor Binding
trapped in an inactive state by a covalent linkage in the
The active site loops in procaspase-7 zymogen are in an unproduc-
interdomain, which also produces a deformed catalytictive conformation for catalysis. The contiguous interdomain loop in
cleft (Figure 1).the procaspase-7 zymogen locks the interdomain loop in a closed
The quaternary structure of caspase-7 comprises twoconformation and precludes a conformational change that must
accompany substrate/inhibitor binding. The proteolytic cleavage closely associated heterodimers, with each heterodimer
after Asp198 rearranges the active site loops and produces a free consisting of a large and a small subunit. Because the
N terminus in the small subunit (L2). These changes ready the active interdomain sequence is inherently flexible and disor-
caspase-7 for substrate/inhibitor binding, which further induces a
dered in solution, two contrasting models of interdomaindrastic conformational switch.
linkage have been proposed based on previous struc-
tural studies on caspase-1 and -3 (Rotonda et al., 1996;
Walker et al., 1994; Wilson et al., 1994). It was suggestedlow temperature factors in the crystals. This gives the
that a drastic conformational change in the L2 loopincorrect impression that the catalytic cleft may be pre-
would have to take place to account for the model informed prior to inhibitor/substrate binding. In compari-
which the adjacent large and small subunits are derivedson, the active site loops in the procaspase-7 zymogen
from the same polypeptide chain. Indeed, relative to theand the isolated active caspase-7 are not stabilized by
inhibitor-bound caspase-7, the L2 loop in the uncleavedthe inhibitor/substrate binding-induced interactions and
procaspase-7 zymogen is flipped by 180 (Figures 1Athus exhibit much greater conformational flexibility. The
and 5). This observation strongly suggests that eachintrinsic conformational flexibility of the active site loops
heterodimer is derived from a single contiguous poly-is essential to the catalytic activity of caspase-7.
peptide, a conclusion further supported by recent inIn this mechanism, the ability of loop L2 to move freely
vitro studies using recombinant proteins (Srinivasula etin response to inhibitor/substrate binding is a decisive
al., 1998a, 1998b). Moreover, the directions of the L2feature. In caspase-7, this ability is acquired through
and L2 loops in procaspase-7 make the other model,proteolytic cleavage after Asp198. Because L2 is at the
in which the interdomain sequence would have to adoptN terminus of the small subunit, our findings predict that
severely restrained conformation, highly unlikely.inverting the order of primary sequences of the large and
In summary, our structural analyses reveal the mecha-small subunits might constitutively activate caspase-7.
nisms of caspase-7 activation and the induced-fit natureAlthough it remains to be formally proved for caspase-7,
of substrate/inhibitor binding for caspase-7. These con-this prediction has been confirmed for two other human
clusions are likely applicable to other caspases andeffector caspases, caspase-3 and -6 (Srinivasula et al.,
should serve a general framework for the understanding1998b) and the Drosophila caspase drICE (Wang et al.,
of caspases.1999). Moreover, the catalytic activity of this reversed
caspase-3 does not require the interdomain cleavage
Experimental Procedures(Srinivasula et al., 1998b), presumably because the L2
loop is free to adopt the open conformation in response
Protein Preparation
to substrate binding. All constructs were generated using a standard PCR-based cloning
In a recent report, an acidic tripeptide (Asp179- strategy, and the identities of individual clones were verified through
double-stranded plasmid sequencing. To avoid autocatalytic cleav-Asp180-Asp181) immediately after the interdomain
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age in bacteria, the full-length procaspase-7 zymogen (residues of caspase-7 variants at room temperature. After extensive washing
with an assay buffer containing 25 mM Tris (pH 8.0), 150 mM NaCl,1–303) contains a missense mutation (C186A) in the active site resi-
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